Moneycontrol PRO
LAMF
LAMF
Jump to
  • Competitive pricing leads to higher volume growth, says Dr Lal Pathlabs

  • Expect 26-27% margins for full year; Q3, Q4 to be good on low base: Dr Lal PathLabs

  • Acquisition in Bangladesh is minor, won't impact FY18 numbers: Dr Lal Pathlab

  • Volume performance to improve going ahead: Dr Lal PathLabs

  • Dr Lal PathLabs to start Kolkata operations next year

  • Dr Lal PathLabs sees margins declining 200-300 bps in 2-3 yrs

  • Dr Lal PathLabs expects good volumes in Q2

  • Confident of beating sector growth of 16-17%: Dr Lal PathLabs

  • Expect Dr Lal PathLabs to surpass industry growth in FY17: CEO

  • May outperform industry's 17% FY17 growth rate forecast: Dr Lal

  • Expect margins to be in range of 25-26%: Dr Lal Pathlabs

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347